Galantamine, which was found to reduce cocaine use in patients treated with methadone for opioid use disorder, may also be effective in reducing the use of nonprescribed opioids in this population.
Group cognitive behavioral therapy was found to benefit patients with chronic pain with low levels of literacy, education, and cognitive memory more than pain psychoeducation.
Intranasal asalhydromorphone was found to reduce opioid abuse-related effects and hydromorphone exposure when compared with intranasal hydromorphone.
Nearly two-thirds of Canadian patients with chronic pain who had contemplated suicide at some point reported being free from suicidal ideation over the past year.
Treatment with buprenorphine-naloxone hydrochloride or extended-release naltrexone hydrochloride may not be associated with pain induction or aggravation of mild to moderate chronic pain.
Cognitive behavioral therapy was found to be more effective in reducing the use of nonmedical opioids compared with standard methadone drug counseling in patients with chronic pain and opioid use disorder enrolled in methadone maintenance treatment programs.
Baseline depressive symptoms were associated with pain and disability in adolescents with juvenile idiopathic arthritis.
The presence of sleep disorders in children with chronic pain may result in greater pain levels and pain interference, a relationship that may in part be mediated by anxiety and depressive symptoms.
Patients with conversion disorder had higher frequencies of significant stressors than did control patients.
Mindfulness, an awareness of one’s present experience without labeling it as good or bad, is a fundamental skill taught in dialectical behavior therapy group skills training.
